WallStreetZenWallStreetZen

NASDAQ: ANAB
Anaptysbio Inc Stock Forecast, Predictions & Price Target

Analyst price target for ANAB

Based on 7 analysts offering 12 month price targets for Anaptysbio Inc.
Min Forecast
$28.00-6.98%
Avg Forecast
$50.00+66.11%
Max Forecast
$80.00+165.78%

Should I buy or sell ANAB stock?

Based on 7 analysts offering ratings for Anaptysbio Inc.
Strong Buy
Strong Buy
4 analysts 57.14%
Buy
2 analysts 28.57%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ANAB stock forecasts and price targets.

ANAB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-10
lockedlocked$00.00+00.00%2024-04-16
lockedlocked$00.00+00.00%2024-04-11
lockedlocked$00.00+00.00%2024-04-01
lockedlocked$00.00+00.00%2024-02-26
Stifel Nicolaus
Bottom 12%
12
Strong BuyInitiates Coverage On$50.00+66.11%2024-02-21
Piper Sandler
Top 5%
96
Strong BuyInitiates Coverage On$80.00+165.78%2024-02-16

1 of 1

Forecast return on equity

Is ANAB forecast to generate an efficient return?
Company
-361.94%
Industry
73.55%
Market
80.58%
ANAB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ANAB forecast to generate an efficient return on assets?
Company
-42.61%
Industry
31.45%
ANAB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ANAB earnings per share forecast

What is ANAB's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
-$6.04
Avg 2 year Forecast
-$6.49
Avg 3 year Forecast
-$5.68

ANAB revenue forecast

What is ANAB's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$36.6M+59.52%
Avg 2 year Forecast
$27.1M+17.83%
Avg 3 year Forecast
$36.9M+60.87%
ANAB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ANAB revenue growth forecast

How is ANAB forecast to perform vs Biotechnology companies and vs the US market?
Company
10.64%
Industry
37.21%
Market
10.62%
ANAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ANAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ANAB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANAB$30.10$50.00+66.11%Strong Buy
MESO$8.05N/AN/A
HUMA$6.99$8.67+23.99%Strong Buy
IMNM$13.49$29.75+120.53%Strong Buy
AUPH$5.61$10.33+84.19%Strong Buy

Anaptysbio Stock Forecast FAQ

Is Anaptysbio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: ANAB) stock is to Strong Buy ANAB stock.

Out of 7 analysts, 4 (57.14%) are recommending ANAB as a Strong Buy, 2 (28.57%) are recommending ANAB as a Buy, 1 (14.29%) are recommending ANAB as a Hold, 0 (0%) are recommending ANAB as a Sell, and 0 (0%) are recommending ANAB as a Strong Sell.

If you're new to stock investing, here's how to buy Anaptysbio stock.

What is ANAB's earnings growth forecast for 2024-2026?

(NASDAQ: ANAB) Anaptysbio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.78%.

Anaptysbio's earnings in 2024 is -$163,300,000.On average, 6 Wall Street analysts forecast ANAB's earnings for 2024 to be -$165,051,051, with the lowest ANAB earnings forecast at -$186,586,339, and the highest ANAB earnings forecast at -$138,778,712. On average, 7 Wall Street analysts forecast ANAB's earnings for 2025 to be -$177,377,224, with the lowest ANAB earnings forecast at -$204,889,830, and the highest ANAB earnings forecast at -$129,217,186.

In 2026, ANAB is forecast to generate -$155,169,898 in earnings, with the lowest earnings forecast at -$204,343,457 and the highest earnings forecast at -$106,542,712.

What is ANAB's revenue growth forecast for 2024-2026?

(NASDAQ: ANAB) Anaptysbio's forecast annual revenue growth rate of 10.64% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.21%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.62%.

Anaptysbio's revenue in 2024 is $22,962,000.On average, 6 Wall Street analysts forecast ANAB's revenue for 2024 to be $1,000,654,611, with the lowest ANAB revenue forecast at $196,120,545, and the highest ANAB revenue forecast at $2,163,090,232. On average, 4 Wall Street analysts forecast ANAB's revenue for 2025 to be $739,105,913, with the lowest ANAB revenue forecast at $327,823,728, and the highest ANAB revenue forecast at $1,278,512,539.

In 2026, ANAB is forecast to generate $1,009,150,709 in revenue, with the lowest revenue forecast at $488,457,355 and the highest revenue forecast at $1,529,844,064.

What is ANAB's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ANAB) forecast ROA is -42.61%, which is lower than the forecast US Biotechnology industry average of 31.45%.

What is ANAB's Price Target?

According to 7 Wall Street analysts that have issued a 1 year ANAB price target, the average ANAB price target is $50.00, with the highest ANAB stock price forecast at $80.00 and the lowest ANAB stock price forecast at $28.00.

On average, Wall Street analysts predict that Anaptysbio's share price could reach $50.00 by May 10, 2025. The average Anaptysbio stock price prediction forecasts a potential upside of 66.11% from the current ANAB share price of $30.10.

What is ANAB's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: ANAB) Anaptysbio's current Earnings Per Share (EPS) is -$6.14. On average, analysts forecast that ANAB's EPS will be -$6.04 for 2024, with the lowest EPS forecast at -$6.83, and the highest EPS forecast at -$5.08. On average, analysts forecast that ANAB's EPS will be -$6.49 for 2025, with the lowest EPS forecast at -$7.50, and the highest EPS forecast at -$4.73. In 2026, ANAB's EPS is forecast to hit -$5.68 (min: -$7.48, max: -$3.90).

What is ANAB's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ANAB) forecast ROE is -361.94%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.